dihydrotestosterone and Hyperaldosteronism
dihydrotestosterone has been researched along with Hyperaldosteronism in 14 studies
Research
Studies (14)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (78.57) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Arteaga, A; Dhand, NK; Eckersall, PD; Evans, H; Knottenbelt, CM; McCann, T; Ramsey, IK; Tebb, AJ | 1 |
Fukuchi, S; Haruyama, K; Shigetomi, S; Yamazaki, M | 1 |
Kimura, M; Nakada, T | 1 |
Ando, A; Hashiba, T; Mikeo, T; Saito, Z; Takeda, J | 1 |
Katayama, T; Nakada, T | 1 |
Vetter, H; Winterberg, B | 1 |
Füessl, HS | 1 |
Corvol, P; Freifeld, M; Mahoudeau, J; Menard, J; Michaud, A | 1 |
Demura, H; Nomura, K; Ujihara, M | 1 |
Griffing, GT; Melby, JC | 1 |
Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M | 1 |
Demura, H; Horiba, N; Nomura, K; Shizume, K | 1 |
Greminger, P; Groth, H; Vetter, H; Vetter, W; Winterberg, B | 1 |
Trials
1 trial(s) available for dihydrotestosterone and Hyperaldosteronism
Article | Year |
---|---|
Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesis.
Topics: Aldosterone; Blood Pressure; Dihydrotestosterone; Diuretics; Double-Blind Method; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension; Hypokalemia; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Prospective Studies; Random Allocation | 1989 |
Other Studies
13 other study(ies) available for dihydrotestosterone and Hyperaldosteronism
Article | Year |
---|---|
Monitoring the response of canine hyperadrenocorticism to trilostane treatment by assessment of acute phase protein concentrations.
Topics: Acute-Phase Proteins; Alkaline Phosphatase; Animals; Biomarkers; C-Reactive Protein; Dihydrotestosterone; Dog Diseases; Dogs; Enzyme Inhibitors; Female; Haptoglobins; Hyperaldosteronism; Male; Serum Amyloid A Protein; Treatment Outcome | 2010 |
[The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)].
Topics: Adult; Aldosterone; Blood Pressure; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Oxidative Phosphorylation; Potassium; Renin | 1982 |
Primary aldosteronism associated with chronic renal failure. Report of a case.
Topics: Adenoma; Adrenal Gland Neoplasms; Combined Modality Therapy; Dihydrotestosterone; Furosemide; Humans; Hyperaldosteronism; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1984 |
[Trilostane therapy in patients with hypercorticism].
Topics: 3-Hydroxysteroid Dehydrogenases; Adult; Cushing Syndrome; Dihydrotestosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Middle Aged; Oxidative Phosphorylation Coupling Factors | 1984 |
[Therapeutic experience of primary aldosteronism associated with chronic renal failure].
Topics: Adrenal Gland Neoplasms; Dihydrotestosterone; Furosemide; Humans; Hyperaldosteronism; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1983 |
[Therapy of primary aldosteronism with trilostane].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Adult; Dihydrotestosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged | 1983 |
Trilostane (Modrenal).
Topics: Cushing Syndrome; Dihydrotestosterone; Humans; Hyperaldosteronism | 1982 |
[Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Algorithms; Cushing Syndrome; Diagnosis, Differential; Dihydrotestosterone; Diuretics; Enzyme Inhibitors; Humans; Hyperaldosteronism; Hypertension; Magnetic Resonance Angiography; Mineralocorticoid Receptor Antagonists; Pituitary Neoplasms; Spironolactone; Tomography, X-Ray Computed | 2002 |
Antiandrogenic effect of spirolactones: mechanism of action.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Binding, Competitive; Canrenoic Acid; Cell Nucleus; Cyproterone; Cytosol; Dihydrotestosterone; Hyperaldosteronism; Hypertension; Male; Prostate; Rats; Receptors, Cell Surface; Spironolactone; Tritium | 1975 |
[Inhibitors of thyroid hormone-, steroid hormone-, and catecholamine-synthesis].
Topics: Antithyroid Agents; Autoimmunity; Catecholamines; Dihydrotestosterone; Humans; Hyperaldosteronism; Immunosuppressive Agents; Methimazole; Methyltyrosines; Metyrapone; Propylthiouracil; Thyroid Hormones | 1991 |
Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor).
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Dehydroepiandrosterone; Desoxycorticosterone; Dihydrotestosterone; Estradiol; Female; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Male; Middle Aged; Oxidative Phosphorylation Coupling Factors; Progesterone; Radioimmunoassay; Renin-Angiotensin System; Testosterone | 1985 |
Long-term treatment of idiopathic hyperaldosteronism using trilostane.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dihydrotestosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Middle Aged; Time Factors | 1986 |
Primary aldosteronism: treatment with trilostane.
Topics: 3-Hydroxysteroid Dehydrogenases; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Blood Pressure; Dihydrotestosterone; Electrolytes; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hyperplasia; Male; Middle Aged; Renin-Angiotensin System | 1985 |